Sign in
Explore the registryTrack Pirtobrutinib's trials

BRUIN-MCL-321

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

PirtobrutinibOngoingActive not recruitingPhase 3Open NCT04662255 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

BRUIN-MCL-321 · Trial Tracker · ComplyRx